Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
Maria Vittoria Cannizzaro, Chiara Franceschini, Maria Esposito, Luca Bianchi, Alessandro Giunta Department of Dermatology, University of Rome Tor Vergata, Rome, Italy Abstract: The risk of hepatitis B virus (HBV) reactivation (HBVr) in chronic HBV carriers, in occult HBV patients or in acute HBV pat...
Guardado en:
Autores principales: | Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de6d257625d343eeb35c247a9792c640 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Lorenzo Onorato, et al.
Publicado: (2021) -
Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients
por: Khan SA, et al.
Publicado: (2018) -
Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
por: Anani HAA, et al.
Publicado: (2020) -
The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection
por: Hiroyuki Amano, et al.
Publicado: (2021) -
Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016)